We are 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid CAS:112811-72-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
CAS.NO: 112811-72-0
Synonyms:
1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Gatifloxacin Carboxyclic Acid
Molecular Formula:C14H11F2NO4
Molecular Weight:295.23800
Physical and Chemical Properties:
Density: 1.174g / cm3
Boiling point: 245.2ºC at 760 mmHg
Melting point: 192-194ºC
Flash point: 102.1ºC
Refractive index: 1.629
Specification:
Appearance: White or off-white crystalline powder
Purity:≥99%
Assay: ≥98.5%
Impurity: ≤0.5%
Relative matter: ≤1.5%
Loss on dry: ≤0.5%
Residue on ignition: ≤0.2%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage: Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Moxifloxacin hydrochloride CAS:186826-86-8
Intermediates of Moxifloxacin CAS:151096-09-2
Related News: Since inception in 2004, ICIG has acquired 15 businesses, all of which have origins in major global chemical or pharmaceutical corporations and are independently managed.Tetraethyl orthosilicate hydrolyzed China has a complete upstream and downstream industry chain, lower costs, and good talent reserves. It is one of the few industries in China that has an advantage in international competition.1-methoxy-3-nitro-5-(trifluoromethyl)benzene CAS:328-79-0 The company has now selected a single engineered iPSC clone, and generated and fully-characterized the master engineered iPSC bank for GMP production of FT819.5-Amino-2,3-dihydrobenzofuran CAS:42933-43-7 Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.
Product Name | |
---|---|
Methyl 6-Bromohexanoate | View Details |
4-Chloro-3-(trifluoromethyl)phenyl isocyanate | View Details |
3-Chloro-5,6-dihydro-1-(4-nitrophenyl)-2(1H)-pyridinone Cas:536760-29-9 | View Details |